Delivery Order SPE2DB22D2007-SPE2DB25FH8PA

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,349.08 firm fixed-price delivery order is for the supply of 4566707309 - IMIQUIMOD 5% CREAM PACKET 24S. The award has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,004.15, is a delivery order for the supply of IMIQUIMOD 5% CREAM PACKET 24S. It is a firm fixed-price contract with an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, with an ID of SPE2DX15D7062|SPE2DX25FJCZT, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,020.00 firm fixed-price delivery order is for the supply of IMIQUIMOD 5% CREAM 24S, a medical product, with a completion date of January 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,890.29, is a delivery order issued by the Defense Logistics Agency (DLA) for the supply of IMIQUIMOD 3.75% CREAM 28S. The contract has a firm fixed price pricing type and an ultimate completion date of February 6, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,406.36 delivery order is for the provision of IMIQUIMOD 5% CREAM PACKET 12S, a pharmaceutical product, with a performance period through April 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Imiquimod 5% Cream Packets 24s. The contract, valued at $1,726.61, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of IMIQUIMOD 3.75% cream pump 7.5 gm to the Defense Logistics Agency (DLA). The award, valued at $1,103.45, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential total value of up to $999,999,999.00 through December 31, 2025. This single-award IDC enables the DLA to efficiently procure a comprehensive range of...
The federal contract award SPE2DX15D7062|SPE2DX24FVZU3 was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product Imiquimod 5% Cream in 24-count packages, with a total ceiling value of $3,604.17. The contract is a Firm Fixed Price Delivery Order with a performance period...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on July 26, 2022. The $1,530.58 firm fixed-price contract is for the delivery of Imiquimod 5% cream packets. The contract has an ultimate completion date of July 27, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Imiquimod 3.75% Cream Pump 7.5gm to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under a Delivery Order with a Firm Fixed Price of $1,585.49. The contract has a completion date of November 13, 2024 and does not have a set-aside designation, indicating open competition....
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH8PA
    Delivery Order

This federal contract award, SPE2DB22D2007|SPE2DB25FH8PA, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,070.35 Firm Fixed Price delivery order is for the supply of IMIQUIMOD 5% CREAM PACKET 24S medical products.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This specific award is not designated as a set-aside contract.

Generated 4/28/25, 9:51 AM